Helix, Competing With Ancestry And 23andMe, Raises $200 Million For Marketing War

The fundraising round, which shows that Helix is able to raise large amounts of money despite criticism of its platform, shows the renewed interest in genetics as a market by big investors.

Source: Forbes.com Healthcare News - March 1, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news